November 19, 2026 at 10:13 PM UTC
Co-Diagnostics, Inc. files current report with SEC
Co-Diagnostics, Inc. filed an 8-K covering SEC Item 3.03, charter, bylaw or fiscal-year changes, and a Regulation FD disclosure. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: November 19, 2026 at 10:10 PM UTC
Open official source